Leonardo Biosystems
Provider of a proprietary multistage drug delivery platform for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€5—7m (Dealroom.co estimates Nov 2011.)
Houston Texas (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $1.3m | Debt | |
$1.3m | Early VC | ||
Total Funding | €1.2m |